🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521808-22-01
Completed Phase II

Effect of perioperative intravenous infusion of lidocaine on the postoperative course and the immune response in patients undergoing surgery for colon cancer - the PILDI study

2025-521808-22-01 · tracked via the Priya Life Science EU tracker
Sponsor
Institute Of Oncology Ljubljana
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Neoplasms
Decision date
13/10/2025
Enrollment target
100
Sites
Slovenia

Condition studied

Colon cancer

Investigational medicinal product(s)

SODIUM CHLORIDELIDOCAINE HYDROCHLORIDE MONOHYDRATE

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male

Primary endpoint

Total opioid analgesic consumption in both groups during the first 24 hours after the surgical procedure, expressed in mg.

Endpoint detail

Time to first postoperative bowel movement in patients of both groups (measured in hours from the end of the surgical procedure).

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521808-22-01 on CTIS ↗ ← All trials in the EU